Physician profile
Daniel E Okorodudu
NPI 1932368768
$11,028.22
in general payments reported to CMS, 2019-2025
51 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $1,017 · 2021: $2,518 · 2022: $3,099 · 2023: $2,775 · 2024: $149 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,375 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,375.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,433.26 | 2019-2025 | Ozempic, Rybelsus, Norditropin |
| Dexcom, INC. | $891.01 | 2019-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $605.14 | 2020-2023 | Farxiga |
| Amarin Pharma, INC. | $556.59 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $532.11 | 2019-2023 | Jardiance |
| Insulet Corporation | $512.66 | 2019-2023 | Omnipod |
| Xeris Pharmaceuticals, INC. | $510.71 | 2020-2023 | Gvoke Hypopen |
| Mannkind Corporation | $496.34 | 2022-2025 | Afrezza |
| Lilly USA, LLC | $478.95 | 2019-2023 | Baqsimi, Jardiance, Lyumjev |
| Sanofi-Aventis U.S. LLC | $431.49 | 2019-2025 | |
| Abbvie INC. | $353.13 | 2021-2023 | |
| Amgen INC. | $309.91 | 2019-2023 | Prolia, Evenity |
| Alexion Pharmaceuticals, INC. | $298.66 | 2019-2023 | Strensiq |
| Esperion Therapeutics, INC. | $278.64 | 2021-2022 | |
| Corcept Therapeutics | $236.68 | 2019-2023 | Korlym |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $232.95 | 2019-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Tandem Diabetes Care, INC. | $232.87 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $215.00 | 2022-2023 | Tymlos |
| Medtronic, INC. | $211.16 | 2021-2025 | Minimed 780g |
| Merck Sharp & Dohme LLC | $200.50 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $174.03 | 2020-2023 | Cycloset |
| Bayer Healthcare Pharmaceuticals INC. | $134.22 | 2021-2023 | |
| Amneal Pharmaceuticals LLC | $118.46 | 2021-2023 | Unithroid |
| Eton Pharmaceuticals, INC. | $112.14 | 2020-2021 | |
| Valeritas, INC. | $108.60 | 2019 | |
| Ibsa Pharma INC. | $99.22 | 2021-2023 | Tirosint, Licart |
| Antares Pharma, INC. | $95.70 | 2019-2022 | |
| Intuity Medical INC | $95.62 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Janssen Pharmaceuticals, INC | $84.43 | 2019-2020 | |
| Alvogen INC | $82.63 | 2022-2023 | Teriparatide |
| Amryt Pharma Holdings LTD | $79.39 | 2022-2023 | Mycapssa |
| Ultragenyx Pharmaceutical INC. | $73.34 | 2021-2022 | |
| Tolmar, INC. | $70.22 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $68.82 | 2021-2022 | |
| Cequr Corporation | $67.69 | 2022-2023 | Cequr Simplicity |
| Kyowa Kirin, INC. | $62.73 | 2023 | Crysvita |
| Pfizer INC. | $61.94 | 2021-2022 | |
| Vistapharm, INC. | $57.25 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $53.01 | 2022 | |
| Grt US Holding, INC. | $51.49 | 2022 | |
| Medtronic Minimed, INC. | $49.08 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $37.67 | 2021-2022 | |
| Ascensia Diabetes Care US INC. | $29.31 | 2021 | |
| Averitas Pharma INC. | $26.93 | 2023 | Qutenza |
| Tolmar Pharmaceuticals, INC. | $25.05 | 2022 | |
| Althera Pharmaceuticals LLC | $19.86 | 2022 | |
| Becton, Dickinson and Company | $16.27 | 2021 | |
| Acella Pharmaceuticals, LLC | $16.25 | 2023 | NP Thyroid 60 |
| Lifescan, INC. | $13.82 | 2023 | |
| Arbor Pharmaceuticals, INC. | $13.36 | 2021 | |
| Vivus LLC | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Okorodudu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.